Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Oxytocin · 1 trial · 3 indications
Time from placement of cervical ripening balloon to delivery
| Arm | Type | Description |
|---|---|---|
| Cervical Ripening Balloon Alone | ACTIVE_COMPARATOR | Multiparous women will begin cervical ripening with a cervical ripening balloon alone. After the balloon is expelled or removed, induction of labor will proceed with pitocin per standard protocol at MacDonald Women's Hospital. |
| Cervical Ripening Balloon + Oxytocin | ACTIVE_COMPARATOR | Multiparous women will begin cervical ripening with a cervical ripening balloon and simultaneous oxytocin. After the balloon is expelled or removed, induction of labor will proceed with pitocin per standard protocol at MacDonald Women's Hospital. |
| Name | Type | Description |
|---|---|---|
| Oxytocin | DRUG | - |
Inclusion Criteria: * Age \> 18 years * Gestational age \> 34 + 0/7 weeks * Prior spontaneous vaginal delivery * Clinical or U/S EFW of \<4500 grams * Singleton gestation * Cervical dilation \<2 cm Exclusion Criteria: * Any contraindication to cervical ripening balloon, pitocin, or vaginal delive...
Oxytocin is a small molecule being studied for cervical ripening and induction of labor. It is being evaluated in a Phase 3 clinical trial in the United States. The study includes women aged 18 years and older who are undergoing cervical ripening, with a focus on multiparity.
Oxytocin is being developed by Community Health Systems, Inc., a company traded on the New York Stock Exchange under the ticker CYH. The company is conducting clinical research on the drug for cervical ripening and induction of labor.
Oxytocin is in Phase 3 clinical development for cervical ripening and induction of labor. It is an investigational drug and has not been approved by the FDA. One Phase 3 trial has been completed, with no active trials currently ongoing.
Oxytocin is being studied in the clinical trial NCT03138252, titled 'Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin.' This Phase 3 trial was completed in the United States and enrolled 180 participants. The trial was randomized and active-controlled, comparing oxytocin against a cervical ripening balloon.
Oxytocin is a distinct drug being studied for cervical ripening and induction of labor. It is being evaluated in combination with or compared to a cervical ripening balloon in clinical trials. The drug is administered to women undergoing labor induction, and its effectiveness is being assessed in a Phase 3 study.